Simon Charles Goodacre

This inventor holds 17 USPTO granted patents and 24 published patent applications, plus 1 CIPO patent and 14 EPO patents. Top assignees: Genentech, Inc., F. Hoffmann-La Roche Ag. Active years: 2010-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Simon Charles Goodacre. Retrieved from https://idiyas.com/inventor/simon-charles-goodacre

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 24)

% Patents Active = 76.5

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 14 (Patent Applications = 18)

Average Co-Inventor Count = 9.6

ph-index = 5

Forward Citations = 81(Granted Patents)

Location History:

Flex Meadow, GB (2013)
Sawbridgeworth, GB (2014)
Essex, GB (2016)
Harlow Essex, GB (2016 - 2020)
Harlow, GB (2010 - 2023)

Company Filing History:

F. Hoffmann-La Roche Ag

patents

Years Active: 2010-2025

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12233052 - Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof (2025-02-25),

2. 11731943 - Therapeutic compounds, compositions and methods of use thereof (2023-08-22),

3. 10966963 - Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof (2021-04-06),

4. 10654867 - Heteroaryl estrogen receptor modulators and uses thereof (2020-05-19),

5. 10053451 - Heterocyclic estrogen receptor modulators and uses thereof (2018-08-21),

6. 9980947 - Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof (2018-05-29),

7. 9873709 - Triazolopyridine compounds, compositions and methods of use thereof (2018-01-23),

8. 9845291 - Estrogen receptor modulators and uses thereof (2017-12-19),

9. 9604984 - 5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereof (2017-03-28),

10. 9440976 - 1,7-diazacarbazoles and methods of use (2016-09-13),

11. 9346815 - 5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereof (2016-05-24),

12. 9309240 - Pyrazolopyridine compounds, compositions and methods of use (2016-04-12),

13. 9216980 - Methods of use of diazacarbazoles for treating cancer (2015-12-22),

14. 8697708 - Azabenzothiazole compounds, compositions and methods of use (2014-04-15),

15. 8501765 - Diazacarbazoles and methods of use (2013-08-06),

Title: The Innovative Contributions of Simon Charles Goodacre

Introduction

Simon Charles Goodacre is a notable inventor based in Harlow, GB. He has made significant contributions to the field of science and technology, holding a total of 17 patents. His work primarily focuses on therapeutic compounds and their applications.

Latest Patents

Among his latest patents are the "Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof." This patent describes tetrahydro-pyrido[3,4-b]indol-1-yl compounds that exhibit estrogen receptor modulation activity. Another significant patent is for "Therapeutic compounds, compositions and methods of use thereof," which details compounds of Formula (I) and their use as Janus kinase inhibitors.

Career Highlights

Throughout his career, Simon has worked with prominent companies such as Genentech, Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Simon has collaborated with notable coworkers, including Jun Liang and Nicholas Charles Ray. Their combined efforts have led to advancements in their respective fields.

Conclusion

Simon Charles Goodacre's contributions to innovation and invention in the field of therapeutic compounds are commendable. His patents and collaborations reflect his dedication to advancing science and technology.

Profile summary based on public USPTO records.